ArticleJournal of clinical medicine2026

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.